Carl Stepnowsky1, Kathleen F Sarmiento2,3, Shay Bujanover4, Kathleen F Villa4, Vicky W Li5, Natalia M Flores6. 1. University of California, San Diego, California. 2. San Francisco VA Health Care System, San Francisco, California. 3. University of California San Francisco, San Francisco, California. 4. Jazz Pharmaceuticals, Palo Alto, California. 5. Kantar Health, New York, New York. 6. Kantar Health, Foster City, California.
Abstract
STUDY OBJECTIVES: Few population-based studies have explored how excessive sleepiness (ES) contributes to burden of illness among patients with obstructive sleep apnea (OSA). METHODS: This study utilized data from the annual, cross-sectional 2016 US National Health and Wellness Survey. Respondents self-reporting an OSA diagnosis were categorized as having ES (Epworth Sleepiness Scale [ESS] score ≥ 11) or not having ES (ESS score < 11). Comorbidities, health-related quality of life (HRQoL), and productivity were examined in three groups: OSA with ES (n = 731), OSA without ES (n = 1,452), and non-OSA controls (n = 86,961). RESULTS: The OSA with ES group had significantly higher proportions of respondents reporting depression (62.4% versus 48.0%), gastroesophageal reflux disease (39.0% versus 29.4%), asthma (26.3% versus 20.7%), and angina (7.8% versus 6.7%) compared to the OSA without ES group (P < .05). After controlling for covariates, the OSA with ES group had significantly lower (worse) scores for mental component score (41.81 versus 45.65 versus 47.81), physical component score (46.62 versus 48.68 versus 51.36), and SF-6D (0.65 versus 0.69 versus 0.73) compared with OSA without ES and non-OSA controls (all P < .001). The OSA with ES group had significantly higher (greater burden) mean rates of presenteeism (25.98% impairment versus 19.24% versus 14.75%), work impairment (29.41% versus 21.82% versus 16.85%), and activity impairment (31.09% versus 25.46% versus 19.93%) compared with OSA without ES and non-OSA controls (all P < .01) after controlling for covariates. CONCLUSIONS: OSA with ES is associated with higher prevalence of comorbidities, reduced HRQoL, and greater impairment in productivity compared to OSA without ES and compared to non-OSA controls.
STUDY OBJECTIVES: Few population-based studies have explored how excessive sleepiness (ES) contributes to burden of illness among patients with obstructive sleep apnea (OSA). METHODS: This study utilized data from the annual, cross-sectional 2016 US National Health and Wellness Survey. Respondents self-reporting an OSA diagnosis were categorized as having ES (Epworth Sleepiness Scale [ESS] score ≥ 11) or not having ES (ESS score < 11). Comorbidities, health-related quality of life (HRQoL), and productivity were examined in three groups: OSA with ES (n = 731), OSA without ES (n = 1,452), and non-OSA controls (n = 86,961). RESULTS: The OSA with ES group had significantly higher proportions of respondents reporting depression (62.4% versus 48.0%), gastroesophageal reflux disease (39.0% versus 29.4%), asthma (26.3% versus 20.7%), and angina (7.8% versus 6.7%) compared to the OSA without ES group (P < .05). After controlling for covariates, the OSA with ES group had significantly lower (worse) scores for mental component score (41.81 versus 45.65 versus 47.81), physical component score (46.62 versus 48.68 versus 51.36), and SF-6D (0.65 versus 0.69 versus 0.73) compared with OSA without ES and non-OSA controls (all P < .001). The OSA with ES group had significantly higher (greater burden) mean rates of presenteeism (25.98% impairment versus 19.24% versus 14.75%), work impairment (29.41% versus 21.82% versus 16.85%), and activity impairment (31.09% versus 25.46% versus 19.93%) compared with OSA without ES and non-OSA controls (all P < .01) after controlling for covariates. CONCLUSIONS: OSA with ES is associated with higher prevalence of comorbidities, reduced HRQoL, and greater impairment in productivity compared to OSA without ES and compared to non-OSA controls.
Authors: Kim L Ward; David R Hillman; Alan James; Alexandra P Bremner; Laila Simpson; Matthew N Cooper; Lyle J Palmer; Annette C Fedson; Sutapa Mukherjee Journal: J Clin Sleep Med Date: 2013-10-15 Impact factor: 4.062
Authors: Bonnie Dean; Daniel Aguilar; Colin Shapiro; William C Orr; Joshua A Isserman; Brian Calimlim; Gregory A Rippon Journal: J Occup Environ Med Date: 2010-02 Impact factor: 2.162
Authors: H Klar Yaggi; John Concato; Walter N Kernan; Judith H Lichtman; Lawrence M Brass; Vahid Mohsenin Journal: N Engl J Med Date: 2005-11-10 Impact factor: 91.245
Authors: Paul E Peppard; Terry Young; Jodi H Barnet; Mari Palta; Erika W Hagen; Khin Mae Hla Journal: Am J Epidemiol Date: 2013-04-14 Impact factor: 4.897
Authors: Merce Gasa; Renaud Tamisier; Sandrine H Launois; Marc Sapene; Francis Martin; Bruno Stach; Yves Grillet; Patrick Levy; Jean-Louis Pepin Journal: J Sleep Res Date: 2013-02-15 Impact factor: 3.981
Authors: Serena Iacono Isidoro; Adriana Salvaggio; Anna Lo Bue; Salvatore Romano; Oreste Marrone; Giuseppe Insalaco Journal: Health Qual Life Outcomes Date: 2013-12-12 Impact factor: 3.186
Authors: Sergio Martinez; Jamie Sullivan; Cara Pasquale; Bill Clark; Elisha Malanga; Sean Deering; Lin Liu; Carl J Stepnowsky Journal: Chronic Obstr Pulm Dis Date: 2022-07-29
Authors: Terri E Weaver; Christopher L Drake; Heike Benes; Thomas Stern; James Maynard; Stephen G Thein; James M Andry; John D Hudson; Dan Chen; Lawrence P Carter; Morgan Bron; Lawrence Lee; Jed Black; Richard K Bogan Journal: Ann Am Thorac Soc Date: 2020-08
Authors: Russell Rosenberg; Michael J Thorpy; Yves Dauvilliers; Paula K Schweitzer; Gary Zammit; Mark Gotfried; Shay Bujanover; Brian Scheckner; Atul Malhotra Journal: J Clin Sleep Med Date: 2022-01-01 Impact factor: 4.062
Authors: Olga Mediano; Sofia Romero-Peralta; Pilar Resano; Irene Cano-Pumarega; Manuel Sánchez-de-la-Torre; María Castillo-García; Ana Belén Martínez-Sánchez; Ana Ortigado; Francisco García-Río Journal: J Clin Med Date: 2019-10-22 Impact factor: 4.241